<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000579859"><TermName>cytarabine liposome</TermName><TermPronunciation>(sy-TAYR-uh-been LY-poh-some)</TermPronunciation><TermDefinition><DefinitionText>A form of the anticancer drug cytarabine that is contained inside very tiny, fat-like particles. It may have fewer side effects and work better than cytarabine. It is used to treat lymphoma that has spread to the meninges (three thin layers of tissue that cover and protect the brain and spinal cord). It is also being studied in the treatment of other types of cancer. It is a type of antimetabolite. Also called Depo-Cyt and liposomal cytarabine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720537" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;cytarabine liposome&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720536" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;liposoma de citarabina&quot;" language="es" id="_4"/><SpanishTermName>liposoma de citarabina</SpanishTermName><SpanishTermDefinition><DefinitionText>Forma de citarabina, un medicamento contra el cáncer, que está contenida en partículas diminutas semejantes a la grasa. Puede tener menos efectos secundarios y ser más eficaz que la citarabina. Se usa para tratar el linfoma que se ha diseminado hasta las meninges (tres capas delgadas de tejido que cubren y protegen el cerebro y la médula espinal). Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. Es un tipo de antimetabolito. También se llama citarabina liposomal y Depo-Cyt.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-12-03</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000544267">Cytarabine Liposome</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
